Keywords: AstraZeneca, Britsol-Myers Squibb, Diabetes, Dapagliflozin, NDA filing, FDA

AstraZeneca/Bristol-Myers diabetes drug dapagliflozin NDA accepted by US FDA

Article | 09 March 2011

Print This

The US Food and Drug Administration has accepted for review a New Drug Application for dapagliflozin, an investigational compound for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in